It was also discovered that miR-24-3p directly targets FGF11 for its activity, while tumor FGF11 levels were positively correlated to CD4+ and CD8+ T cell counts in vivo, which were predicative of favorable patient disease-free survival. This evidence concerns the gene CD8A and neoplasm.